Financials data is unavailable for this security.
View more
Year on year Transmedics Group Inc grew revenues 158.53% from 93.46m to 241.62m while net income improved from a loss of 36.23m to a smaller loss of 25.03m.
Gross margin | 60.71% |
---|---|
Net profit margin | 0.84% |
Operating margin | -0.22% |
Return on assets | 0.41% |
---|---|
Return on equity | 1.79% |
Return on investment | 0.44% |
More ▼
Cash flow in USDView more
In 2023, Transmedics Group Inc increased its cash reserves by 96.01%, or 193.63m. Cash Flow from Financing totalled 400.42m or 165.72% of revenues. In addition the company used 13.03m for operations while cash used for investing totalled 193.95m.
Cash flow per share | 0.5146 |
---|---|
Price/Cash flow per share | 299.04 |
Book value per share | 5.70 |
---|---|
Tangible book value per share | 5.29 |
More ▼
Balance sheet in USDView more
Current ratio | 9.37 |
---|---|
Quick ratio | 8.48 |
Total debt/total equity | 2.67 |
---|---|
Total debt/total capital | 0.7278 |
More ▼